Global Genetic Testing Market 2022-2028
SKU ID :TNV-11701880 | Published Date: 21-Feb-2018 | No. of pages: 140Description
TOC
Table of ContentsPART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: RESEARCH METHODOLOGY
PART 04: MARKET LANDSCAPE
• Market ecosystem
• Market characteristics
• Market segmentation analysis
PART 05: MARKET SIZING
• Market definition
• Market sizing 2017
• Market size and forecast 2017-2022
PART 06: FIVE FORCES ANALYSIS
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition
PART 07: SEGMENTATION BY APPLICATION
• Overview
• Predictive and diagnostic testing
• Prenatal, newborn, and pre-implantation testing
• Pharmacogenomic testing
• Forensic, relationship, and ancestry testing
PART 08: SEGMENTATION BY PRODUCT
• Overview
• Comparison by product
• Analyzers
• Consumables
• Market opportunity by product
PART 09: CUSTOMER LANDSCAPE
PART 10: SEGMENTATION BY END-USER
• Overview
• Clinical diagnostics laboratories
• Hospitals
• Biopharmaceuticals companies and research centers
PART 11: REGIONAL LANDSCAPE
• Geographical segmentation
• Regional comparison
• Genetic testing market in Americas
• Genetic testing market in EMEA
• Genetic testing market in APAC
• Market opportunity
PART 12: DECISION FRAMEWORK
PART 13: DRIVERS AND CHALLENGES
• Market drivers
• Market challenges
PART 14: MARKET TRENDS
• Growing demand for companion diagnostics
• Availability of NGS for present and future genetic diagnosis
• Growing adoption of DTC genetic testing
PART 15: VENDOR LANDSCAPE
• Overview
• Landscape disruption
• Competitive landscape
PART 16: VENDOR ANALYSIS
• Vendors covered
• Vendor classification
• Market positioning of vendors
• Abbott
• bioMérieux
• Bio-Rad Laboratories
• F. Hoffmann-La Roche
• Myriad Genetics
• QIAGEN
• Quest Diagnostics
PART 17: APPENDIX
• List of abbreviations
Exhibit 01: Parent market: Global IVD market
Exhibit 02: Global IVD market: Segments
Exhibit 03: Market characteristics
Exhibit 04: Global genetic testing market: Segments
Exhibit 05: Market definition: Inclusions and exclusions checklist
Exhibit 06: Global genetic testing market size 2017
Exhibit 07: Validation techniques employed for market sizing 2017
Exhibit 08: Global genetic testing market 2017-2022 ($ millions)
Exhibit 09: Global genetic testing market: Year-over-year growth 2018-2022 (%)
Exhibit 10: Five forces analysis 2017
Exhibit 11: Five forces analysis 2022
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition: Five forces 2017
Exhibit 18: Global genetic testing market: Segmentation by application 2017 (% share)
Exhibit 19: Global genetic testing market: Segmentation by product 2017-2022 (% share)
Exhibit 20: Global genetic testing market: Comparison by product
Exhibit 21: Global genetic testing analyzers market 2017-2022 ($ millions)
Exhibit 22: Global genetic testing analyzers market: Year-over-year growth 2018-2022 (%)
Exhibit 23: Global genetic testing consumables market 2017-2022 ($ millions)
Exhibit 24: Global genetic testing consumables market: Year-over-year growth 2018-2022 (%)
Exhibit 25: Market opportunity by product
Exhibit 26: Customer landscape
Exhibit 27: Global genetic testing market: Segmentation by end-user 2017 (% share)
Exhibit 28: Global genetic testing market: Segmentation by geography 2017-2022 (% share)
Exhibit 29: Regional comparison
Exhibit 31: Genetic testing market in Americas 2017-2022 ($ millions)
Exhibit 32: Genetic testing market in Americas: Year-over-year growth 2018-2022 (%)
Exhibit 33: Top-three countries in Americas
Exhibit 34: Genetic testing market in EMEA 2017-2022 ($ millions)
Exhibit 35: Genetic testing market in EMEA: Year-over-year growth 2018-2022 (%)
Exhibit 36: Top-three countries in EMEA
Exhibit 37: Genetic testing market in APAC 2017-2022 ($ millions)
Exhibit 38: Genetic testing market in APAC: Year-over-year growth 2018-2022 (%)
Exhibit 39: Top-three countries in APAC
Exhibit 40: Market opportunity
Exhibit 41: Product approvals in few countries and their market impact analysis
Exhibit 42: Vendor landscape
Exhibit 43: Landscape disruption
Exhibit 44: Vendors covered
Exhibit 45: Vendor classification
Exhibit 46: Market positioning of vendors
Exhibit 47: Abbott: Overview
Exhibit 48: Abbott: Business segments
Exhibit 49: Abbott: Organizational developments
Exhibit 50: Abbott: Geographic focus
Exhibit 51: Abbott: Segment focus
Exhibit 52: Abbott: Key offerings
Exhibit 53: Abbott: Key customers
Exhibit 54: bioMérieux: Overview
Exhibit 55: bioMérieux: Business segments
Exhibit 56: bioMérieux: Organizational developments
Exhibit 57: bioMérieux: Geographic focus
Exhibit 58: bioMérieux: Segment focus
Exhibit 59: bioMérieux: Key offerings
Exhibit 60: bioMérieux: Key customers
Exhibit 61: Bio-Rad Laboratories: Overview
Exhibit 62: Bio-Rad Laboratories: Business segments
Exhibit 63: Bio-Rad Laboratories: Organizational developments
Exhibit 64: Bio-Rad Laboratories: Geographic focus
Exhibit 65: Bio-Rad Laboratories: Segment focus
Exhibit 66: Bio-Rad Laboratories: Key offerings
Exhibit 67: Bio-Rad Laboratories: Key customers
Exhibit 68: F. Hoffmann-La Roche: Overview
Exhibit 69: F. Hoffmann-La Roche: Business segments
Exhibit 70: F. Hoffmann-La Roche: Organizational developments
Exhibit 71: F. Hoffmann-La Roche: Geographic focus
Exhibit 72: F. Hoffmann-La Roche: Segment focus
Exhibit 73: F. Hoffmann-La Roche: Key offerings
Exhibit 74: F. Hoffmann-La Roche: Key customers
Exhibit 75: Myriad Genetics: Overview
Exhibit 76: Myriad Genetics: Business segments
Exhibit 77: Myriad Genetics: Organizational developments
Exhibit 78: Myriad Genetics: Geographic focus
Exhibit 79: Myriad Genetics: Segment focus
Exhibit 80: Myriad Genetics: Key offerings
Exhibit 81: Myriad Genetics: Key customers
Exhibit 82: QIAGEN: Overview
Exhibit 83: QIAGEN: Product categories
Exhibit 84: QIAGEN: Organizational developments
Exhibit 85: QIAGEN: Geographic focus
Exhibit 86: QIAGEN: Product categories focus
Exhibit 87: QIAGEN: Key offerings
Exhibit 88: QIAGEN: Key customers
Exhibit 89: Quest Diagnostics: Overview
Exhibit 90: Quest Diagnostics: Business segments
Exhibit 91: Quest Diagnostics: Organizational developments
Exhibit 92: Quest Diagnostics: Geographic focus
Exhibit 93: Quest Diagnostics Segment focus
Exhibit 94: Quest Diagnostics Key offerings
Exhibit 95: Quest Diagnostics: Key customers
Tables & Figures
Companies
Abbott
bioMérieux
Bio-Rad Laboratories
F. Hoffmann-La Roche
Myriad Genetics
QIAGEN
Quest Diagnostics
- PRICE
-
$2500$4000